Life Sciences & Healthcare

The life sciences and healthcare sector encompasses one of the most dynamic and vital industries in the global economy, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and digital health solutions. This sector operates within an exceptionally complex regulatory framework, with companies facing stringent oversight from multiple regulatory authorities at national and international levels.

Borenius represented Teva Pharmaceuticals in a patent and supplementary protection certificate disputeIntellectual Property, Life Sciences & Healthcare/5 Sep 2025
Borenius secures win for Teva in a patent dispute over blockbuster anticoagulant drugIntellectual Property, Life Sciences & Healthcare/30 May 2024
Borenius advised Heraeus in a complex trade secret dispute in the Market CourtIntellectual Property, Life Sciences & Healthcare/24 Feb 2020
Borenius Secures Victory for Teva and Mylan in SPC Dispute over Blockbuster DrugIntellectual Property, Life Sciences & Healthcare/27 Sep 2019
Borenius successfully represented Mylan before the Supreme Court in a landmark case concerning the presumption of validityIntellectual Property, Life Sciences & Healthcare/17 Apr 2019
Borenius successfully represented Orifarm Generics at The Court of AppealIntellectual Property, Life Sciences & Healthcare, Litigation & Arbitration/30 Oct 2018
Borenius advised Valio Ltd on the sale of its starter culture ingredients business to Chr. Hansen A/S and its related supply, licence and IPR arrangementsCommercial Contracts, Corporate Advisory & Compliance, Intellectual Property, Life Sciences & Healthcare, M&A & Private Equity/13 Sep 2016

Life Sciences & Healthcare

Rankings: recent highlights